Works matching IS 02683369 AND DT 2005 AND VI 36 AND IP 9

Results: 12

What would Karl Landsteiner do? The ABO blood group and stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 747, doi. 10.1038/sj.bmt.1705101

By:

Heal, J. M.;
Liesveld, J. L.;
Phillips, G. L.;
Blumberg, N.

Publication type:

Article

Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab.

Published in:

Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 797, doi. 10.1038/sj.bmt.1705121

By:

Lamba, R.;
Carrum, G.;
Myers, G. D.;
Bollard, C. M.;
Krance, R. A.;
Heslop, H. E.;
Brenner, M. K.;
Popat, U.

Publication type:

Article

Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease.

Published in:

Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 825, doi. 10.1038/sj.bmt.1705130

By:

Toze, C. L.;
Galal, A.;
Barnett, M. J.;
Shepherd, J. D.;
Conneally, E. A.;
Hogge, D. E.;
Nantel, S. H.;
Nevill, T. J.;
Sutherland, H. J.;
Connors, J. M.;
Voss, N. J.;
Kiss, T. L.;
Messner, H. A.;
Lavoie, J. C.;
Forrest, D. L.;
Song, K. W.;
Smith, C. A.;
Lipton, J.

Publication type:

Article

Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 793, doi. 10.1038/sj.bmt.1705131

By:

Chang, H.;
Qi, X. Y.;
Samiee, S.;
Yi, Q.-L.;
Chen, C.;
Trudel, S.;
Mikhael, J.;
Reece, D.;
Stewart, A. K.

Publication type:

Article

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time.

Published in:

Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 757, doi. 10.1038/sj.bmt.1705140

By:

Gratwohl, A.;
Brand, R.;
Frassoni, F.;
Rocha, V.;
Niederwieser, D.;
Reusser, P.;
Einsele, H.;
Cordonnier, C.

Publication type:

Article

Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry.

Published in:

Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 787, doi. 10.1038/sj.bmt.1705141

By:

Donadieu, J.;
Michel, G.;
Merlin, E.;
Bordigoni, P.;
Monteux, B.;
Beaupain, B.;
Leverger, G.;
Laporte, J. P.;
Hermine, O.;
Buzyn, A.;
Bertrand, Y.;
Casanova, J. L.;
Leblanc, T.;
Gluckman, E.;
Fischer, A.;
Stephan, J. L.

Publication type:

Article

Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with the HLA-A02 or HLA-A24 phenotype undergoing hematopoietic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 803, doi. 10.1038/sj.bmt.1705133

By:

Morita, Y.;
Hosokawa, M.;
Ebisawa, M.;
Sugita, T.;
Miura, O.;
Takaue, Y.;
Heike, Y.

Publication type:

Article

Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH)

Published in:

Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 781, doi. 10.1038/sj.bmt.1705135

By:

Diaz, M. A.;
Gonzalez-Vicent, M.;
Gonzalez, M. E.;
Verdeguer, A.;
Martinez, A.;
Perez-Hurtado, M.;
Badell, I.;
de la Rubia, J.;
Bargay, J.;
de Arriba, F.;
Diez, J. L.;
Caballero, D.;
Madero, L.;
Brunet, S.

Publication type:

Article

OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease.

Published in:

Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 831, doi. 10.1038/sj.bmt.1705132

By:

Knop, S.;
Hebart, H.;
Gscheidle, H.;
Holler, E.;
Kolb, H.-J.;
Niederwieser, D.;
Einsele, H.

Publication type:

Article

High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 813, doi. 10.1038/sj.bmt.1705134

By:

Asano-Mori, Y.;
Oshima, K.;
Sakata-Yanagimoto, M.;
Nakagawa, M.;
Kandabashi, K.;
Izutsu, K.;
Hangaishi, A.;
Motokura, T.;
Chiba, S.;
Kurokawa, M.;
Hirai, H.;
Kanda, Y.

Publication type:

Article

Cardiac complications after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab.

Published in:

Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 821, doi. 10.1038/sj.bmt.1705145

By:

Oshima, K.;
Sakata-Yanagimoto, M.;
Asano-Mori, Y.;
Izutsu, K.;
Watanabe, T.;
Shoda, E.;
Ogawa, S.;
Motokura, T.;
Chiba, S.;
Kurokawa, M.;
Hirai, H.;
Kanda, Y.

Publication type:

Article

Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspects.

Published in:

Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 771, doi. 10.1038/sj.bmt.1705138

By:

Rossi, J.-F.;
Fegueux, N.;
Lu, Z. Y.;
Legouffe, E.;
Exbrayat, C.;
Bozonnat, M.-C.;
Navarro, R.;
Lopez, E.;
Quittet, P.;
Daures, J.-P.;
Rouillé, V.;
Kanouni, T.;
Widjenes, J.;
Klein, B.

Publication type:

Article

Works matching IS 02683369 AND DT 2005 AND VI 36 AND IP 9

What would Karl Landsteiner do? The ABO blood group and stem cell transplantation.

Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab.

Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease.

Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation.

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time.

Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry.

Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with the HLA-A<sup></sup>02 or HLA-A<sup></sup>24 phenotype undergoing hematopoietic stem cell transplantation.

Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH)

OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease.

High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation.

Cardiac complications after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab.

Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m<sup>2</sup> of melphalan in multiple myeloma: results of a pilot study including biological aspects.